Redefining sequencing from genomics to 5D multiomics! Join us to explore the new AVITI24 from Element Biosciences – a powerful platform enabling ultra-sensitive, tumor-informed MRD analysis from tissue to plasma. Learn how this next-generation system is shaping the future of relapse prediction in solid tumors and advancing single-cell multiomics research. Stay for a pizza lunch following the session.

Speaker:
Dr. Matthew Gow (Technical Sales Specialist Element Biosciences)
Dr. Christian Gloeckner (Senior Director Research & Innovation Haystack Oncology GmbH)

Contact at Element Biosciences:
Dr. Sonja Rausch - sonja.rausch@elembio.com